finasteride has been researched along with Prostatic Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauersachs, J; Bavendiek, U; Bea, M; Elling, LS; Heineke, J; Kattih, B; Weiss, C; Zwadlo, C | 1 |
| De Nunzio, C; Finazzi Agrò, E; Miano, R; Trucchi, A; Tubaro, A | 1 |
| Chorzepa-Nowicka, K; Gaczarzewicz, D; Laszczyńska, M; Piasecka, M; Wylot, M | 1 |
| Schröder, FH | 1 |
| Holm, M; Meyhoff, HH | 1 |
| Jung, K; Lein, M; Loening, SA; Meyer, A; Rudolph, B; Schnorr, D | 1 |
| Agusta, VE; Breslin, JA; Harpster, LE; Huffnagle, HW; Rommel, FM; Sieber, PR | 1 |
| Sorrentino, F; Sorrentino, M | 1 |
| Bergh, A; Damber, JE; Lekås, E | 1 |
| Armenakas, NA; Basillote, JB; Fracchia, JA; Hochberg, DA; Pareek, G; Shevchuk, M; Vasovic, L | 1 |
3 review(s) available for finasteride and Prostatic Diseases
| Article | Year |
|---|---|
Finasteride for prostatic disease: an updated and comprehensive review.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Dose-Response Relationship, Drug; Enzyme Inhibitors; Finasteride; Humans; Male; Meta-Analysis as Topic; Prostatic Diseases; Randomized Controlled Trials as Topic | 2008 |
[Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
Topics: Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Male; Oxidoreductases; Prostatic Diseases; Prostatic Hyperplasia | 2008 |
5 alpha-reductase inhibitors and prostatic disease.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgens; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Finasteride; Humans; Male; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1994 |
7 other study(ies) available for finasteride and Prostatic Diseases
| Article | Year |
|---|---|
Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgen Antagonists; Cardiomegaly; Case-Control Studies; Chronic Disease; Cross-Sectional Studies; Finasteride; Heart Failure; Humans; Male; Propensity Score; Prostatic Diseases; Retrospective Studies | 2019 |
Chronic prostatic pain. A new treatment option with finasteride?
Topics: Adult; Aged; Chronic Disease; Enzyme Inhibitors; Finasteride; Humans; Long-Term Care; Male; Middle Aged; Pain; Prostatic Diseases; Recurrence; Urodynamics | 1997 |
Factors influencing the ratio of free to total prostate-specific antigen in serum.
Topics: Adult; Aged; Aged, 80 and over; Aging; alpha 1-Antichymotrypsin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Diseases; Protein Binding; Reference Values | 1997 |
The treatment of gross hematuria secondary to prostatic bleeding with finasteride.
Topics: Aged; Aged, 80 and over; Enzyme Inhibitors; Finasteride; Hematuria; Hemorrhage; Humans; Male; Prostatic Diseases | 1998 |
Re: The treatment of gross hematuria secondary to prostatic bleeding with finasteride.
Topics: Enzyme Inhibitors; Finasteride; Hematuria; Hemorrhage; Humans; Male; Prostatic Diseases | 1998 |
Effects of finasteride and bicalutamide on prostatic blood flow in the rat.
Topics: Androgen Antagonists; Anilides; Animals; Enzyme Inhibitors; Finasteride; Male; Nitriles; Organ Size; Prostate; Prostatic Diseases; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Tosyl Compounds | 2000 |
Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia.
Topics: Aged; Enzyme Inhibitors; Finasteride; Hemorrhage; Humans; Male; Microcirculation; Prospective Studies; Prostate; Prostatic Diseases; Prostatic Hyperplasia | 2002 |